Cytokinetics Inc share price logo

Cytokinetics Inc

NASDAQ: CYTK

Large Cap

$74.76

+0.20

(+0.27%)

as on

Cytokinetics Inc Stock Performance

as on May 13, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $73.13
    $75.23
    downward going graph

    2.18%

    Downside

    0.63%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $29.31
    $80.20
    downward going graph

    60.79%

    Downside

    7.28%

    Upside

    downward going graph

Cytokinetics Inc share price movements today

Previous Close
$74.56
Open
$74.68
Volume
1.9M
Day's Low - High
$73.13 - $75.23
52 Week Low - High
$29.31 - $80.20

Cytokinetics Inc Historical Returns

1 Month Return
+ 14.69 %
3 Month Return
+ 14.64 %
1 Year Return
+ 132.06 %
3 Year Return
+ 98.09 %
5 Year Return
+ 206.58 %

Cytokinetics Inc Stock Fundamentals & Key Indicators

Check Cytokinetics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$10.1B

EPS (TTM)

-6.6057

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

-0.42

EBITDA

-629.0M

Revenue (TTM)

105.8M

Profit Margin

0.00%

Return On Equity TTM

-572.15%

Cytokinetics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cytokinetics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$10.1B206.58%NA0.00%
BUY$39.4B113.59%74.1312.55%
NA$32.2BNA70.468.94%
BUY$109.1B104.61%25.5135.51%
BUY$74.9B40.55%17.4529.65%

Stock Returns calculator for Cytokinetics Inc Stock including INR - Dollar returns

The Cytokinetics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cytokinetics Inc investment value today

Current value as on today

₹2,62,102

Returns

₹1,62,102

(+162.1%)

Returns from Cytokinetics Inc Stock

₹1,32,680 (+132.68%)

Dollar Impact

₹29,422 (+29.42%)

Analyst Recommendation on Cytokinetics Inc Stock

Based on 25 analysts

BUY

84.00%

Buy

16.00%

Hold

0.00%

Sell

Based on 25 analysts, 84% of analysts recommend a 'BUY' rating for Cytokinetics Inc. Average target price of $104.53

Cytokinetics Inc Share Price Target

Get share price movements and forecasts by analysts on Cytokinetics Inc.

What analysts predicted

28.48%UPSIDE

Target Price

$104.53

Current Price

$74.76

Analyzed by

25 Analysts

Target

$104.53

Cytokinetics Inc target price $104.53, a slight upside of 28.48% compared to current price of $74.76. According to 25 analysts rating.

Indian Investors' Interest in Cytokinetics Inc Stock

Search interest for Cytokinetics Inc Stock has increased by 229% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:229% versus previous 30 day period

Cytokinetics Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
1
0
0
0
16
1
66
1
17
19
Gross Profit
-83
-80
-79
-84
-76
-98
64
0
14
16
Operating Income
-127
-126
-130
-140
-139
-155
-111
-166
-178
-183
EBITDA
-113
-115
-116
-135
-125
-136
-107
-277
-180
-180
Interest Expense
17
17
24
22
22
22
24
26
30
33
Depreciation
6
2
2
2
2
2
2
2
2
3
Income Before Tax
-136
-135
-143
-160
-150
-161
-134
-306
-183
-206
Income Tax Expense
1
2
-
-
-
-
-
-
-
-
Net Income
-136
-135
-143
-160
-150
-161
-134
-306
-183
-206
Net Profit Margin
-8187.56%
-16244.67%
-57557.43%
-34674.95%
-886.28%
-10220.14%
-201.25%
-15814.98%
-1030.87%
-1064.48%

Cytokinetics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
106
13
31
26
55
70
94
7
18
88
Gross Profit
46
-76
-57
-59
-41
-89
-146
-322
-320
77
Operating Income
18
-113
-88
-98
-93
-186
-324
-496
-536
-612
EBITDA
19
-108
-83
-93
-86
-176
-329
-456
-493
-775
Interest Expense
2
16
21
27
38
29
51
57
86
103
Depreciation
-
1
1
1
1
2
5
7
9
10
Income Before Tax
16
-127
-106
-121
-127
-215
-388
-526
-589
-784
Income Tax Expense
0
0
4
27
36
27
13
11
-
-
Net Income
16
-127
-106
-121
-127
-215
-388
-526
-589
-784
Net Profit Margin
15.46%
-955.94%
-337.41%
-452.93%
-228.00%
-305.72%
-411.21%
-6988.63%
-3191.11%
-891.60%

Cytokinetics Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-135
-143
-160
-150
-161
-134
-306
-183
-206
Operating Cash Flow
-129
-99
-101
-65
-131
-128
-107
-142
-145
Investing Cash Flow
32
-651
-45
110
105
52
-70
-71
145
Financing Cash Flow
103
821
3
2
4
78
330
110
7
Change in Cash
6
70
-143
47
-21
2
152
-102
7

Cytokinetics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-127
-106
-121
-127
-215
-388
-526
-589
-784
Operating Cash Flow
-101
-101
-90
8
-142
-299
-414
-395
-510
Investing Cash Flow
-65
5
-74
-196
-147
-262
239
-553
16
Financing Cash Flow
225
13
159
234
319
516
221
930
524
Change in Cash
58
-82
-5
46
29
-45
46
-18
30

Global Institutional Holdings in Cytokinetics Inc

Funds
Holdings
Bank of America Corp
2.39%
Charles Schwab Investment Management Inc
1.13%
Northern Trust Corp
1.12%
T. Rowe Price Investment Management,Inc.
22.05%
AllianceBernstein L.P.
1.16%

Cytokinetics Inc News & Key Events

  • img

    Today's Timeline - 18 September

    Thu, 06:00 PM

    -

    Cytokinetics faces class action lawsuit for misleading investors about FDA drug approval timeline and omitted key regulatory requirements.

    Fri, 02:35 AM

    -

    Cytokinetics stock dropped over 15% after FDA extended review period for aficamten due to incomplete submission.

Insights on Cytokinetics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 1.93M → 19.35M (in $), with an average increase of 48.7% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, CYTK has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, CYTK has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, CYTK stock has moved up by 143.6%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -183.03M → -206.03M (in $), with an average decrease of 12.6% per quarter

About Cytokinetics Inc

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.
OrganisationCytokinetics Inc
Headquarters350 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
IndustryBiotechnology
CEOMr. Robert I. Blum
E-voting on sharesClick here to vote

Key Management of Cytokinetics Inc

Name

Title

Mr. Robert I. Blum

CEO, President & Director

Dr. Fady Ibraham Malik FACC, M.D., Ph.D.

Executive Vice President of Research & Development

Dr. James H. Sabry M.D., Ph.D.

Co-Founder & Chairman of Scientific Advisory Board

Mr. Steven M. Cook J.D.

Senior Vice President of Global Supply Chain Operations & Technical Operations

Mr. Sung H. Lee

EVP & CFO

Mr. Jeffrey J. Hessekiel J.D.

Executive VP, Chief Legal & Administrative Officer

Mr. Andrew M. Callos

Executive VP & Chief Commercial Officer

Dr. James A. Spudich Ph.D.

Co-Founder & Member of Scientific Advisory Board

Mr. Jeff Lotz

Vice President of Sales & Operations

Ms. Holly Laughlin

VP of Accounting & Corporate Controller

FAQs

What is Cytokinetics Inc share price today?

Cytokinetics Inc share price today is $74.76 as on at the close of the market. Cytokinetics Inc share today touched a day high of $75.23 and a low of $73.13.

What is the 52 week high and 52 week low for Cytokinetics Inc share?

Cytokinetics Inc share touched a 52 week high of $80.2 on and a 52 week low of $29.31 on . Cytokinetics Inc stock price today i.e. is closed at $74.76,which is 6.78% down from its 52 week high and 155.07% up from its 52 week low.

What is Cytokinetics Inc's market capitalisation today?

Cytokinetics Inc market capitalisation is $0.01T as on .

How to invest in Cytokinetics Inc Stock (CYTK) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cytokinetics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cytokinetics Inc Shares that will get you 0.0201 shares as per Cytokinetics Inc share price of $74.76 per share as on May 13, 2026 at 1:29 am IST.

What is the minimum amount required to buy Cytokinetics Inc Stock (CYTK) from India?

Indian investors can start investing in Cytokinetics Inc (CYTK) shares with as little as ₹95.618 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.18 in Cytokinetics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Cytokinetics Inc share’s latest price of $74.76 as on May 13, 2026 at 1:29 am IST, you will get 0.1338 shares of Cytokinetics Inc. Learn more about fractional shares .

What are the returns that Cytokinetics Inc has given to Indian investors in the last 5 years?

Cytokinetics Inc stock has given 206.58% share price returns and 29.61% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?